Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cvr Partners LP Unit | UAN | Nov 14, 2024 | 72.32 | +1.54 |
CVRx | CVRX | Nov 14, 2024 | 14.13 | -0.49 |
CVS Health | CVS | Nov 14, 2024 | 55.09 | +1.51 |
CXApp A | CXAI | Nov 14, 2024 | 1.43 | +0.70 |
CyberArk Software | CYBR | Nov 14, 2024 | 301.28 | +3.32 |
Cybin | CYBN | Nov 14, 2024 | 11.00 | +4.76 |
Cyclacel Pharmaceuticals | CYCC | Nov 14, 2024 | 0.39 | -12.60 |
Cyclacel Pharmaceuticals Pref | CYCCP | Nov 14, 2024 | 6.97 | +14.26 |
Cyclerion Therapeutics | CYCN | Nov 14, 2024 | 1.77 | -1.67 |
Cyclo Therapeutics | CYTH | Nov 14, 2024 | 0.61 | -14.63 |
Cyngn | CYN | Nov 14, 2024 | 7.08 | -1.26 |
Cytek Biosciences | CTKB | Nov 14, 2024 | 6.42 | -5.31 |
Cytokinetics | CYTK | Nov 14, 2024 | 54.70 | -2.25 |
Cytomed Therapeutics | GDTC | Nov 14, 2024 | 2.12 | -4.50 |
CytomX Therapeutics | CTMX | Nov 14, 2024 | 1.00 | -0.99 |
Cytosorbents | CTSO | Nov 14, 2024 | 0.95 | +2.59 |
D-MARKET Electronic Services & Trading ADR | HEPS | Nov 14, 2024 | 2.93 | -2.33 |
D-Wave Quantum | QBTS | Nov 14, 2024 | 1.87 | +5.06 |
D.R. Horton | DHI | Nov 14, 2024 | 163.74 | +1.62 |
Dada Nexus ADR | DADA | Nov 14, 2024 | 1.37 | -12.74 |
Daily Journal | DJCO | Nov 14, 2024 | 558.29 | -2.12 |
Dakota Gold | DC | Nov 14, 2024 | 2.19 | -1.35 |
Daktronics | DAKT | Nov 14, 2024 | 14.75 | -0.34 |
DallasNews A | DALN | Nov 14, 2024 | 5.11 | -8.26 |
Dana | DAN | Nov 14, 2024 | 8.34 | -2.46 |
Danaher | DHR | Nov 14, 2024 | 239.38 | -0.89 |
Danaos | DAC | Nov 14, 2024 | 85.91 | -0.14 |
Danimer Scientific | DNMR | Nov 14, 2024 | 8.81 | -16.02 |
DAQO New Energy ADR | DQ | Nov 14, 2024 | 20.14 | -2.89 |
Darden Restaurants | DRI | Nov 14, 2024 | 168.69 | -0.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.